Author

Hannah J. Sfreddo

Memorial Sloan Kettering Cancer CenterORCID 0000-0002-7169-0673Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Cristina ValeroiD· 1 shared Diego ChowelliD· 1 shared Eytan RuppiniD· 1 shared Luc G.T. MorrisiD· 1 shared Saugato Rahman DhrubaiD· 1 shared Se‐Hoon LeeiD· 1 shared Seong‐Keun YooiD· 1 shared Tiangen ChangiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Cristina ValeroORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyNature CancerPeer-reviewedJun 3, 2024

Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features

Tiangen Chang, Yingying Cao, Hannah J. Sfreddo…·Eytan Ruppin

This study develops a logistic regression model to predict immune checkpoint blockade response and survival in cancer patients using common clinical and genomic features.

151 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky